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ABSTRACT
Background: Cerebral amyloid angiopathy (CAA) is a disorder characterized by amyloid
deposition in the wall of cerebral blood vessels. The deposits of amyloid occur frequently in the
blood vessels of the frontal, parietal and occipital cortex.
Objective: To examine the characteristics of CAA classified according to the Vonsattel scale in
elderly dogs histologically and immunohistochemically as well as the semi-quantitative
evaluation of the amyloid deposits in the different segments of the brain.
Animals and methods: The brains of 36 dogs of different breeds and sexes, which had been
routinely necropsied, were used and divided into two groups: dogs from 1 to 5 and 10 to 18
years old. The tissue sections were stained by hematoxylin–eosin, Congo red and
immunohistochemically.
Results: Amyloid was accumulated in the wall of cerebral blood vessels in 70% of dogs over the
age of 10 years predominantly in the frontal cortex. CAA was demonstrated in elderly dogs as
follows: in the frontal cortex (n D 19 or 63%), the parietal cortex (n D 12 or 40%), the
hippocampus (40%) and the cerebellum (n D 5 or 17%). The deposits of amyloid in the wall of
blood vessels detected by Congo red staining were also Ab1-14 and Ab1-42
immunohistochemically positive. Most commonly, the amyloid deposits affected a moderate
number of blood vessels. The accumulation of amyloid was immunohistochemically revealed in
the blood vessel walls as well as in the senile plaques and neurons.
Conclusion: The amount of amyloid in the arterial walls increased with age in dogs, whereas the
amyloid accumulated in plaques was Congo red negative.
KEYWORDS
Dog; canine; brain; amyloid;
angiopathy
1. Introduction
Amyloidoses are diseases with a heterogenic range
and are characterized by interstitial deposition and
accumulation of amyloid. Potentially, deposits of amy-
loid can be found in all tissues. Cerebral amyloid angi-
opathy (CAA) is characterized by the deposition and
accumulation of beta amyloid (Ab) in cerebral vascula-
ture (Gahr et al. 2013). The term CAA refers to a hetero-
genic group of illnesses of the central nervous system,
which are characterized histopathologically by the
presence of amyloid in the wall of cerebral blood ves-
sels (Biffi & Greenberg 2011; Gahr et al. 2013). CAA in
humans can be divided into two forms: hereditary and
sporadic. The occurrence of the hereditary (familiar)
form is related to various forms of mutations (Thanvi &
Robinson 2006; Yamada & Naiki 2012; Gahr et al. 2013).
The sporadic form occurs much more frequently and
mostly as a sporadic condition in the elderly, with an
increasing incidence associated with age. This form is a
very common finding in the brain of patients with Alz-
heimer’s disease (AD) (Vinters et al. 1996; Revesz et al.
2002; Kumar-Singh 2008; Mendel et al. 2013). CAA in
the animal brain is also related to aging (Walker 1997;
Borras et al. 1999). The presence of amyloid in the
blood vessel walls of senile dementia patients was first
described by Scholtz in 1938 (Sholtz, 1938). Although
amyloid in peripheral organs has been studied in
experimental animals since the early part of the twenti-
eth century, CAA was not described in a non-human
species until the 1950s, when Von Braunm€uhl (1956)
reported senile plaques and congophilic angiopathy in
aged dogs. CAA was described in various animal spe-
cies such as a transgenic mouse, bear, cat, dog, mon-
key, camel, etc. (Walker 1997; Nakayama et al. 1999;
Papaioannou et al. 2001; Rofina et al. 2006; Elfenbein
et al. 2007).
Amyloid deposits most often occur in the frontal, tem-
poral and occipital cortex. This abnormal protein accu-
mulates in the wall of all blood vessel types of the
cerebrum and cerebellum gray matter. Deposits of amy-
loid are rarely present in the blood vessels of white mat-
ter (Vinters et al. 1996; Revesz et al. 2002; Kumar-Singh
2008). It has been widely accepted that Ab in the wall of
cerebral vasculature is toxic to the vascular elements and
causes structural and functional alterations of the blood
vessels. Several studies have shown that endothelial
cells and pericytes undergo degeneration in amyloid-
laden vessels (Farkas & Luiten 2001; Kumar-Singh et al.
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2002). Other structural changes such as microangiop-
athy, microaneurysmal dilatation, necrosis, etc. can also
be observed in the cerebral blood vessel walls (Vinters
et al. 1996; Revesz et al. 2002; Kumar-Singh 2008).
Furthermore, CAA independently contributes to demen-
tia and it is a risk factor for hemorrhagic stroke (Kumar-
Singh 2008). Some studies have shown that CAA in the
brain of a dog has a positive correlation with the fre-
quency of hemorrhage (Uchida et al. 1991; Walker 1997)
and cognitive decline (Cummings et al. 1996; Head et al.
1998; Head et al. 2000).
The amyloid protein/peptide present in the vascular
deposits of CAA is identical to the beta amyloid found
in the senile plaques in human patients with AD. Many
amyloid isoforms accumulate in the brain such as Ab
1-40/1-42/1-43/3pE/pN3 (Schilling et al. 2008; Cham-
bers et al. 2011; Saito et al. 2011; Mendel et al. 2013). In
tissue, beta amyloid can be detected by Congo red
staining as well as by immunohistochemical staining
(Papaioannou et al. 2001).
The aim of the work was to examine the characteris-
tics of CAA in the elderly dog population histologically
and immunohistochemically as well as the semi-quan-
titative evaluation of the amyloid deposits in the differ-
ent segments of the brain of elderly dogs.
2. Materials and methods
In this study, we examined the brains of 36 dogs of dif-
ferent breeds and sexes, which had been routinely nec-
ropsied at the Department of Veterinary Pathology of
the Faculty of Veterinary Medicine, University of Bel-
grade (Table 1). The animals without clinical neurologi-
cal signs or mental or behavioral dysfunctions during
life, died or were euthanized for a variety of reasons.
The examined dogs had been divided in two groups:
group of young dogs (group A) consisted of six dogs
(from 1 to 5 years old) and group of elderly dogs
(group B) composed of 30 dogs (10–18 years old). After
necropsy, the brains were removed, macroscopically
examined and fixed in 10% neutral buffered formalin
for six days. Coronal sections of the frontal cerebral cor-
tex, parietal cerebral cortex, hippocampus, cerebellum
and medulla oblongata were routinely processed,
embedded in paraffin, cut into 4–6 mm thick sections
and stained using the hematoxylin and eosin, and the
Congo red method. The stained tissues were analyzed
by the light microscope and some of the sections with
characteristic findings were captured by a digital cam-
era. The additional analyses of the sections stained by
Congo red were done under polarized light. The fre-
quency of CAA observed in each Congo red positive
Table 1 Age, sex and breed of examined dogs (nos. 1–6 group of young dogs and nos. 7–36 group of elderly dogs).




euthanized Reason of death or euthanasia
Group A (young dogs) 1 Mixed M 8 months D Hemorrhagic enteritis
2 Boxer F 2 D Traumatic bleeding
3 American Staford Terrier M 2,5 D Pneumonia
4 West Highland White
Terrrier
M 1,9 D Hemorrhagic enteritis
5 Mixed F 5 E Pulmonary embolism
6 Chau chau F 4,5 D Heart failure
Group B (elderly dogs) 7 Pekingeze F 12 D Mammary carcinoma
8 Irish Setter F 13 D Mammary carcinoma
9 Mixed M 15 E Liver neoplasia, pneumonia
10 English Cocker Spaniel F 12 E Mammary carcinoma
11 Mixed M 17 E Cirrhosis of kidney
12 Sarplaninac F 15 E Cirrhosis of liver and kidney
13 Pekingeze F 14 E Cirrhosis of liver and kidney
14 Mixed M 18 E Neoplasia in the abdominal cavity
15 Mixed F 12 E Lymphoma
16 Medium Poodle M 14 D Heart failure
17 Mixed F 14,5 E Neoplasia in the neck
18 Rottweiler M 13 D Dilatation and torsion of the stomach
19 Mixed M 15 E Renal infarction
20 Mixed F 12 E Liver necrosis, cirrhosis of kidney and pyometra
21 American Staford Terrier F 12 E Neoplasia in the spleen
22 Mixed F 18 E Lung atelectasis Heart failure, cirrhosis of liver and kidney
23 English Cocker Spaniel F 10 E Neoplasia in the pancreas with metastasis in the body
24 Irish Setter F 14 E Cirrhosis of liver and kidney
25 Mixed F 15 E Neoplasia, heart failure, pancreatic necrosis
26 Labrador M 13 E Neoplasia in the lung
27 Bull Terrier M 12 E Megacolon, cirrhosis of liver
28 Mixed F 16 E Cirrhosis of liver and kidney calcification heart valvule
29 German Shepherd Dog M 13 D Heart failure. gastritis, enteritis
30 Mixed F 14 E Cirrhosis of kidney, necrosis and hemorrhages in the
pancreas
31 Maltese F 13 E Hydrometra, cirrhosis of liver and kidney
32 Medium Poodle M 16 E Endocardiosis, Cirrhosis of liver and kidney
33 Mixed M 16,5 E Mucometra, ovarian and kidney cysts, hydrothorax and
hydroperitoneum
34 Mixed M 16 E Cirrhosis of liver
35 Mixed F 12 E Neoplasia in the urinary bladder, cirrhosis of liver
36 Mixed M 17 D Rib fractures
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section was recorded according to a semi-quantitative
grading scheme based on the number of Congo red
positive vessels in the total number of vessels observed
in 10 fields using 10x objective (100x magnification).
After counting, the percentage of positive blood ves-
sels were calculated and compared to the total number
of vessels in each sample (number of positive/total
number of blood vessels £ 100). Based on the
obtained results, the percentage of blood vessels with
amyloid deposited was determined 0% (¡), 1%–29%
(C low number of positive blood vessels), 30%–69%
(CC, moderate number of positive blood vessels) and
>70% (CCC, numerous positive blood vessels)
(Figure 1).
In humans, the severity of CAA has been classified
according to the Vonsattel scale as follows: mild,
moderate and severe forms. The mild form is charac-
terized by deposits of Ab restricted to the congo-
philic rim around normal or atrophic smooth muscle
fibers. In the moderate form, the tunica media is
thicker than normal and is replaced by deposits of
Ab amyloid, with no evidence of blood leakage. The
massive deposits of Ab with focal wall fragmentation
and at least one focus of perivascular leakage as evi-
denced by the presence of erythrocytes or hemosid-
erin, or both, are characteristics of the severe form
(Vonsattel et al. 1991; Vinters et al. 1996; Revesz
et al. 2002; Kumar-Singh 2008; Mendel et al. 2013). In
this study, CAA has been classified according to the
Vonsattel scale.
The estimated proportion of beta amyloid deposit
involvement in each blood vessel was recorded on the
Mountjoy scale from 0 to 4. A score of 0 indicated the
absence of amyloid. The finding of Ab deposits of up
to one-quarter of the vessel circumference was score 1.
A score 2 marked Ab deposits in up to one-half of the
vessel circumference. The involvement of amyloid of
up to three-quarters of the vessel circumference was
score 3. Finally, score 4 indicated the total involvement
of the vessel circumference (Mountjoy et al. 1982; Men-
del et al. 2013).
Immunohistochemical staining was performed by
the commercial kit LSAB2 (Labeled streptavidin-bio-
tin2, DAKO, Glostrup, Denmark). As a negative control
we used brain samples of young dogs that should not
have been positive. In addition to the brain of young
dogs, the brain of dogs that had not been treated with
primary antibody was used as a negative control for
immunohistochemical staining. The control slides were
treated with a buffer (phosphate buffer solution (PBS))
instead of primary antibody. Polyclonal antibody
against Ab 1-14 (AbD serotec, Langford, UK, working
dilutions 1:400) and monoclonal antibody against Ab
1-42 (Invitrogen, Camarillo, CA, USA, working dilutions
1:500) were used as primary antibodies. The sections
were incubated in 85% formic acid for 10 minutes to
enhance the beta amyloid immunoreaction. PBS (pH
7.2–7.4) was used for rinsing. Both antibodies were
incubated in a moist chamber at a temperature of 18–
20 C for 60 minutes. After incubation with the primary
antibody, the sections were treated by commercial kit
for detection (Dako, Cytomation, Glostrup, Denmark,
LSAB2 System-HRP, K0675). The chromogen 3.3'-diami-
nobenzidine tetrahydrochloride (DABC, DAKO,
Glostrup, Denmark, K3468) was used for staining the
antibody–antigen complex.
3. Results
No amyloid deposits were found in the brain of dogs
from group A. The accumulation of amyloid in the
brain of dogs from group B was proven by Congo red
and immunohistochemical staining. The amyloid
stained by the Congo red method was characterized as
a red homogeneous structure under the light micro-
scope, while it was fluorescent yellow–green under the
polarized light (Figure 2). Deposits were found in the
meningeal and parenchymal blood vessels in all exam-
ined regions of the brain, except in the medulla oblon-
gata. CAA was demonstrated by Congo red staining in
the frontal cortex of 19 dogs (63%), the parietal cortex
Figure 1 Congo red staining (semi-quantitative evaluation), magnification 100x: (A) gradeC (low number of the positive blood ves-
sels of Congo red positive vessels in the total number of vessels in field), (B) grade CC (moderate number of Congo red positive
vessels in the total number of vessels in field).
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of 12 dogs (40%), hippocampus of 12 dogs (40%) and
the cerebellum of 5 dogs (17%).
In all Congo red positive cases, amyloid deposits
were always present in the wall of meningeal blood
vessels. Moreover, this pathological protein was found
in the wall of parenchymal blood vessels of the frontal
cortex in 13 dogs (43%), of the parietal cortex in 9 dogs
(30%), of the hippocampus in 7 dogs (23%) and in the
blood vessel walls of the cerebellum in 4 dogs (13%).
Congo red positive blood vessels were never observed
in subcortical white matter. Semi-quantitive evaluation
of Congo-red-stained sections (Table 2) showed that
CAA, including meningeal and parenchymal blood ves-
sel, was present in frontal sections of 63% of dogs, in
parietal sections of 40% of dogs, in the hippocampus
of 40% of dogs and in the cerebellum of 17% of dogs.
In this study, a moderate number of congophilic blood
vessels in the frontal section were observed in 27% of
dogs and numerous congophilic blood vessels in the
frontal section were present in 13% of dogs. The lowest
number of positive blood vessels was observed in the
cerebellum (17%). In this study, of the total number of
the examined dogs, 13% had a moderate number of
positive blood vessels in the cerebellum.
The amyloid deposits were observed immunohisto-
chemically in the wall of blood vessels, diffuse plaques
and in some cases intraneuronally. The amyloid depos-
its were Ab1–14 immunohistochemically positive in all
of the three locations, while the deposits in the vascu-
lature and in the plaques were only Ab1–42 immuno-
histochemically positive.
In almost all dogs (90%) with cerebrovascular amy-
loidosis, amyloid was accumulated in the meningeal
and parenchymal blood vessel walls (Figure 3(A,B)). A
small number of dogs (10%) had deposits of amyloid
only in the meningeal blood vessels, while none of the
dogs had amyloid only in the parenchymal blood
vessels.
Using immunohistochemical staining, the amyloid
deposits were detected in the blood vessel walls of all
examined segments of the brain except in the medulla
oblongata. The amyloid deposits were most frequently
present in the wall of blood vessels of the frontal cor-
tex, and were the least common in the cerebellum. In
the meningeal blood vessels, the presence of amyloid
deposits has been shown in the frontal cortex of
21 dogs (70%), in the parietal cortex of 16 dogs (53%),
in the hippocampus of 15 dogs (50%) and in the cere-
bellum of 5 dogs (17%). The presence of amyloid was
detected in the parenchymal blood vessels of the brain
in the frontal cortex in 70% of dogs, in the parietal cor-
tex in 50% of dogs, hippocampus in 50% of dogs and
in the parenchymal blood vessels of the cerebellum in
13.33% of dogs from the group B.
Amyloid deposits were observed in the various
layers of the wall of the blood vessel. In this study,
three forms of CAA were identified according to the
Vonsattel scale (mild, moderate and severe (Figure 3)).
All forms of amyloid deposits according to the Mount-
joy scale were observed (Figure 3). In some cases, they
formed a ring around the entire blood vessel, while in
other cases, their presence was intermittent and lim-
ited to one-quarter, one-half or three-quarters of the
vessel circumference. There was no cellular response
around the blood vessels caused by the amyloid
deposits in any case. Diffuse plaques (Figure 3(C)) were
present in the brain of 19 dogs (63%) from the group
B. Beta amyloid positive plaques were observed most
frequently in the frontal cortex. The presence of pla-
ques was less frequently (43%–53%) immunohisto-
chemically proven in other examined tissue sections,
while they were not observed at all in the cerebellum
and the medulla oblongata. In this study, the amyloid
Figure 2 Congo red staining of the brain of aged dogs: (A) amyloid in the wall of meningeal blood vessel (arrow), frontal section;
(B) amyloid in the wall of meningeal blood vessel (arrow), frontal section, under the polarized light; (C) amyloid in the wall of men-
ingeal blood vessels of cerebellum (arrow), under polarized light.
Table 2 Semi-quantitive evaluation of the cerebral amyloid









¡ 37 60 60 83
C 23 13 17 4
CC 27 20 17 13
CCC 13 7 6 0
Note: Degree of CAA: ¡, no positive blood vessels;C low number of
the positive blood vessels; CC, moderate number of the positive
blood vessels; CCC numerous positive blood vessels).
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accumulated in plaques was Congo red negative. Intra-
neuronal accumulation of amyloid was demonstrated
only by immunohistochemical staining. The intra-
neuronal deposits in the frontal and parietal cortex as
well as in the hippocampus were Ab1–14 immunohis-
tochemically positive in seven dogs (23%, Figure 3(D)).
All brains of the dogs from the group A were Ab1–14
immunohistochemically negative.
4. Discussion
The changes in the blood vessels of the brain tissue
may occur during the aging process and significantly
affect the viability of neurons and glial cells and thus
can damage the structure and function of the central
nervous system. The lesions in the blood vessels can
occur in the perivascular space, the wall or in the
lumen. The most important and the most common
changes during the aging process are the changes in
the structure of the cerebral blood vessel walls, which
may lead to changes in permeability, which in turn dis-
rupts the normal flow of glucose and oxygen to neu-
rons and glial cells, so that hypoxia and lack of
nutrients lead to cell damage (Dimakopoulos & Mayer
2002).
The accumulation of amyloid in the blood vessel
walls is a significant lesion in old patients, patients with
familiar CAA and in almost all patients with AD (Vinters
et al. 1996; Revesz et al. 2002; Kumar-Singh 2008). In
this study, it has been found that amyloid was accumu-
lated in the wall of cerebral blood vessels in 70% of
dogs over the age of 10 years. These results confirm
that CAA is an age-dependent change. The amount of
amyloid in the arterial walls increased with age which
correlated with findings of Rofina et al. 2006, but in our
study amyloid plaques in cortex were Congo red nega-
tive which is not in accordance with the results of these
authors (Rofina et al. 2006). Recent data show that
there are three types of amyloid plaques: diffuse, primi-
tive and neuritic (Dimakopoulos & Mayer 2002; Brellou
et al. 2005). The diffuse plaques are believed to further
‘mature’ into dense core plaques such as primitive or
neuritic plaques. The dense core plaques often contain
dystrophic neurites and higher burden of Ab 1–40,
whereas the diffuse plaques are composed predomi-
nantly Ab 1–42 and occur mostly perineuronally and
occasionally as large ‘clouds’. Only diffuse plaques are
not detectable by Congo red staining. These plaques
are the predominant subtype of Ab in the aging dog
brain (Cummings et al. 1996; Head et al. 1998; Head
et al. 2000; Brellou et al. 2005), but in several studies,
the primitive plaques have been found in the brain of
elderly dog (Papaioannou et al. 2001; Rofina et al.
2006).
Amyloid accumulates in the wall of the leptomenin-
geal and parenchymal blood vessels. It is believed that
Ab accumulated in the wall of a cerebral blood vessel
has a toxic effect on vascular elements. Consequently,
Figure 3 (A) b-amyloid deposits in the wall of meningeal blood vessels (arrow), anti-Ab1-42, frontal section; (B) b-amyloid deposits
in the wall of parenchymal blood vessels (arrow – severe type of the Vonsattel scale and score 4 of the Mountjoy scale, arrowhead
– mild type of the Vonsattel scale and score 1 of the Mountjoy scale), anti-Ab 1-14, frontal section; (C) diffuse plaque (arrow), anti-
Ab 1-42 parietal section; (D) intracellular b-amyloid deposits (arrow), anti-Ab 1-14, parietal section.
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endothelial cells and pericytes are the subject of
degeneration (Farkas & Luiten 2001; Kumar-Singh et al.
2002). Considering that amyloid affects vascular per-
meability, it causes poor perfusion of the brain and
indirectly leads to neuronal damage. The results
obtained in this study showed that the majority of the
dogs in the experimental group had CAA that affected
the leptomeningeal and parenchymal blood vessels at
the same time, while a small number of dogs revealed
the presence of amyloid only in the wall of the lepto-
meningeal blood vessels.
It is believed that the appearance of CAA in humans
is associated with the occurrence of dementia. In addi-
tion to the CAA as a factor that affects the occurrence
of dementia, it is also a risk factor for the occurrence of
hemorrhage in the brain (Kumar-Singh 2008). Hemor-
rhage was not found in any of the examined brains in
our study. The absence of hemorrhage might be due
to the fact that dogs from the experimental group
were of different breeds and therefore had different
life spans.
Age-related CAA has been noted in a variety of ver-
tebrate species (Walker 1997; Kumar-Singh et al. 2000;
Brellou et al. 2005; Elfenbein et al. 2007). The lack of
appropriate animal models is an obstacle to under-
standing CAA (Revesz et al. 2003; Elfenbein et al. 2007),
but presently there are a few well-established, natural
models of sporadic CAA. Aged dogs and non-human
primates have been used often as natural models of
CAA (Walker & Cork 1999; Walker & Durham 1999;
Walker 2000; Elfenbein et al. 2007). Dogs are particu-
larly suitable for modeling the human process of aging
and sporadic CAA, since they share a number of bio-
logical similarities and living space with humans, and
because CAA is primarily a form of cerebral b-amyloid-
osis in this species. In this study, we confirmed that
dogs are predisposed to age-related CAA, and showed
that (1) amyloidotic blood vessels in the brain of dogs
are congophilic; (2)Ab accumulated in all types of cere-
bral blood vessels as well as deposits involve different
layers of the blood vessel walls; (3) deposits of amyloid
can affect from one-quarter to the entire circumference
of the wall of cerebral vessels; (4) Ab1–42 exists in most
microvascular and parenchymal lesions in dogs over 10
years; (5) the density and anatomical distribution of
CAA and parenchymal plaques overlap; (6)Tte most fre-
quently affected region is the frontal cortex, with Ab
deposits primarily in the parenchyma and blood vessel
walls; (7) deposits of amyloid in plaques and intra-
neuronally are Congo red negative.
So far, there are no data about the semi-quantitative
evaluation of CAA neither in dogs nor other animals.
This study contains first semi-quantitative evaluation
of the CAA in dogs that presents the percentage of
affected blood vessels depending on the brain seg-
ment of the Congo red positive cases. The obtained
results may indicate a connection between changes in
the brain’s blood vessels and functional disorders that
can manifest as behavioral disorders in dogs which
was shown in the study of Rofina and coworkers
(Rofina et al. 2006) previously.
5. Conclusion
Sporadic CAA is an age-related change in the brain of
the elderly. This study showed that amyloid deposit
was always present in the walls of meningeal blood
vessels, but in the brain parenchyma, the amyloid
deposits were most frequently present in the wall of
blood vessels of the frontal cortex. There is no defini-
tive premortem diagnosis or treatment for CAA. Animal
models are a critical link in the chain of discovery lead-
ing to the development of diagnostic and therapeutic
tools for CAA. In the future, the further successful incor-
poration of animal models into examinations may be
helpful in understanding the development of CAA in
AD and other disorders.
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